355 related articles for article (PubMed ID: 27198736)
1. Reduced lysosomal acid lipase activity - A potential role in the pathogenesis of non alcoholic fatty liver disease in pediatric patients.
Selvakumar PK; Kabbany MN; Lopez R; Tozzi G; Alisi A; Alkhouri N; Nobili V
Dig Liver Dis; 2016 Aug; 48(8):909-13. PubMed ID: 27198736
[TBL] [Abstract][Full Text] [Related]
2. Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease.
Ferri F; Mischitelli M; Tozzi G; Messina E; Mignini I; Mazzuca S; Pellone M; Parisse S; Marrapodi R; Visentini M; Baratta F; Del Ben M; Pastori D; Perciballi R; Attilia ML; Carbone M; De Santis A; Violi F; Angelico F; Ginanni Corradini S
Clin Transl Gastroenterol; 2020 Feb; 11(2):e00116. PubMed ID: 32463622
[TBL] [Abstract][Full Text] [Related]
3. Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
Baratta F; Pastori D; Ferro D; Carluccio G; Tozzi G; Angelico F; Violi F; Del Ben M
World J Gastroenterol; 2019 Aug; 25(30):4172-4180. PubMed ID: 31435171
[TBL] [Abstract][Full Text] [Related]
4. Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver Disease.
Shteyer E; Villenchik R; Mahamid M; Nator N; Safadi R
Int J Mol Sci; 2016 Feb; 17(3):312. PubMed ID: 26927097
[TBL] [Abstract][Full Text] [Related]
5. A Relative Deficiency of Lysosomal Acid Lypase Activity Characterizes Non-Alcoholic Fatty Liver Disease.
Tovoli F; Napoli L; Negrini G; D'Addato S; Tozzi G; D'Amico J; Piscaglia F; Bolondi L
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587063
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease.
Baratta F; Pastori D; Tozzi G; D'Erasmo L; Di Costanzo A; Arca M; Ettorre E; Ginanni Corradini S; Violi F; Angelico F; Del Ben M
Liver Int; 2019 Dec; 39(12):2301-2308. PubMed ID: 31392821
[TBL] [Abstract][Full Text] [Related]
7. Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease.
Polimeni L; Pastori D; Baratta F; Tozzi G; Novo M; Vicinanza R; Troisi G; Pannitteri G; Ceci F; Scardella L; Violi F; Angelico F; Del Ben M
Intern Emerg Med; 2017 Dec; 12(8):1159-1165. PubMed ID: 28900817
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
[TBL] [Abstract][Full Text] [Related]
9. Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease.
Baratta F; Pastori D; Del Ben M; Polimeni L; Labbadia G; Di Santo S; Piemonte F; Tozzi G; Violi F; Angelico F
EBioMedicine; 2015 Jul; 2(7):750-4. PubMed ID: 26288848
[TBL] [Abstract][Full Text] [Related]
10. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
[TBL] [Abstract][Full Text] [Related]
11. Elevated Hemoglobin Level Is Associated With Advanced Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.
Giorgio V; Mosca A; Alterio A; Alisi A; Grieco A; Nobili V; Miele L
J Pediatr Gastroenterol Nutr; 2017 Aug; 65(2):150-155. PubMed ID: 28737569
[TBL] [Abstract][Full Text] [Related]
12. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
[TBL] [Abstract][Full Text] [Related]
13. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
Akyuz U; Yesil A; Yilmaz Y
Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
[TBL] [Abstract][Full Text] [Related]
14. Folate and B12 Levels Correlate with Histological Severity in NASH Patients.
Mahamid M; Mahroum N; Bragazzi NL; Shalaata K; Yavne Y; Adawi M; Amital H; Watad A
Nutrients; 2018 Apr; 10(4):. PubMed ID: 29614799
[TBL] [Abstract][Full Text] [Related]
15. Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes: Evidence in NAFLD patients and cell cultures.
Gomaraschi M; Fracanzani AL; Dongiovanni P; Pavanello C; Giorgio E; Da Dalt L; Norata GD; Calabresi L; Consonni D; Lombardi R; Branchi A; Fargion S
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Dec; 1864(12):158523. PubMed ID: 31505261
[TBL] [Abstract][Full Text] [Related]
16. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
[TBL] [Abstract][Full Text] [Related]
17. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
18. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.
McPherson S; Hardy T; Henderson E; Burt AD; Day CP; Anstee QM
J Hepatol; 2015 May; 62(5):1148-55. PubMed ID: 25477264
[TBL] [Abstract][Full Text] [Related]
19. Low levels of Lysosomal Acid Lipase (LAL) activity increases necroinflammation in adult patients with biopsy-proven metabolic associated fatty liver disease.
Thoen RU; Longo L; Neto SC; Álvares-da-Silva MR
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101638. PubMed ID: 33662773
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis?
Gravito-Soares M; Gravito-Soares E; Gomes D; Tome L
Ann Hepatol; 2019; 18(1):78-88. PubMed ID: 31113613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
